List your practice on InjuredCare | Log in / Sign up

Adderall and Ritalin

Adderall and Ritalin

Drugs Commonly Used to Treat Attention Deficit Hyperactivity Disorder (ADHD)

Adderall and Ritalin are prescription drugs used to treat individuals with attention deficit hyperactivity disorder (ADHD) and narcolepsy, a condition involving difficulty managing sleep-wake cycles. ADHD is most commonly found in young children and adolescents and is characterized by difficulty paying attention, excessive activity, busyness, or behavior that is age inappropriate. Adderall is what is known as a "combination medication," containing four different types of amphetamines. Ritalin is the trade name for the chemical compound methylphenidate. Both Adderall and Ritalin are stimulants.

Adderall is actually a rebrand or renaming of an earlier drug known as Obetrol. Obetrol was marketed in the 1960s as a weight-control drug but was pulled from the market in 1973 by its manufacturer, Rexar. Rexar reformulated the product and brought it back on the market. In 1994, Richwood Pharmaceuticals acquired Rexar, renamed Obetrol as Adderall (a contraction of "A.D.D. for All") and began marketing it for the treatment of attention deficit disorder. After discussions with the FDA, Adderall was approved for sale and marketing in the United States in 1996.

Methylphenidate was first synthesized in 1944 and was used in the 1960s to treat children diagnosed with ADHD. The FDA approved Ritalin for sale and marketing in the United States in 1961. An extended release form was approved by the FDA in 2000, sold under the brand name Concerta.

Adderall has been tied to a wide range of adverse side effects, often based on dosage. Physical side effects include cardiovascular problems, often related to high or low blood pressure. Adderall also has been linked to Raynaud's phenomenon, where patients experience reduced blood flow to extremities. A number of gastrointestinal conditions are associated with the drug, including nausea, diarrhea, constipation, and abdominal pain. Users have reported loss of appetite, dry mouth, blurred vision, weight loss, seizures, and excessive grinding of the teeth. Sexual dysfunction also may be a consequence.

Though Ritalin has generally been well-tolerated, patients have reported interruptions in sleep patterns, heart problems, anxiety, and weight loss.

Related Articles

  • Onglyza

    Onglyza

    Onglyza was co-formulated by Bristol-Myers Squibb and AstraZeneca in 2007. On July 31, 2009, it was approved by the FDA for treatment of type-2 diabetes. Its key active ingredient, Read More...

  • Drug and Medical Device Injuries

    Drug and Medical Device Injuries

    Certain pharmaceutical drugs and medical devices have been linked to cancer, stroke, internal bleeding, and a number of other medical conditions. Opioid addiction has become a wide Read More...

  • Avandia

    Avandia

    The Trade Name for the Diabetes Drug Rosiglitazone Avandia is a prescription drug, patented in 1987 and approved by the Food and Drug Administration (FDA) for use in the United St Read More...

© 2015-2022 LawConnect, Inc. All rights reserved.

CONCEPT, DESIGN and HOSTING BY GETLEGAL.COM’S WEB SERVICES TEAM..